Institute of Information Management (IIM) Australia Successfully Concludes 2025 Annual Conference, Induction & Investiture in Brisbane
With the theme "Navigating Data Integrity and Compliance in the Australian Digital Landscape," the event brought together distinguished professionals, industry leaders, inductees, and guests from both the public and private sectors. Participants joined both in person and virtually to explore emerging challenges and opportunities in data governance.
The conference began with an opening address by IIM International President, Amb. (Dr.) Oyedokun Ayodeji Oyewole, CCDOA, FIIM. In his remarks, Dr. Oyewole emphasized the growing significance of data integrity and compliance in an era of rapid technological change and increasing regulatory demands.
A key highlight of the day was the keynote presentation delivered by Ms. Kate Carruthers (FGIA, MAICD), Director of Info Sphere Education Pty Ltd, Sydney. Her address, titled "The New Rules of Data: Compliance, Conflict, and Competitive Advantage," offered attendees a compelling exploration of the evolving regulatory environment in Australia and beyond. Ms. Carruthers examined global data management trends, the human dimension of data, and practical strategies for organizations navigating new compliance frameworks.
She shed light on critical developments such as the Privacy and Other Legislation Amendment Act (December 2024), the Cyber Security Act 2024, and updated standards impacting critical infrastructure and financial institutions. Emphasizing integrated federal legislation, mandatory ransomware reporting, and enhanced protections for vulnerable groups—including children and victims of doxing—Ms. Carruthers underscored the imperative for organizations to embed data integrity, trust, and transparency into their core operations.
The event also featured the formal induction of new members into the IIM Australia community across various categories, including Honorary Fellow, Professional Fellow, and Associate Member. The investiture ceremony recognized these individuals' outstanding contributions to the field of information management and their dedication to upholding professional excellence.
The 2025 Annual Conference reaffirmed IIM Australia's unwavering commitment to promoting thought leadership, regulatory awareness, and excellence in data governance amid the ongoing digital transformation.
For further information about IIM Australia and upcoming events, please contact:
Institute of Information Management (IIM) AustraliaHillcrest, Queensland AustraliaEmail: info@iim-africa.org
Celestine AchiCell: +234-08099997175Email: Celestine.achi@gmail.com
Photo - https://mma.prnewswire.com/media/2668645/IIM.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/institute-of-information-management-iim-australia-successfully-concludes-2025-annual-conference-induction--investiture-in-brisbane-302432964.html
SOURCE Institute of Information Management
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
43 minutes ago
- Yahoo
Gogoro to Announce Second Quarter 2025 Financial Results on August 12th at 8 a.m. Eastern Time
TAIPEI, July 28, 2025 /PRNewswire/ -- Gogoro® Inc. (Nasdaq: GGR), a global technology leader in battery swapping ecosystems that enable sustainable mobility solutions for cities, today announced that it will release its financial results for the second quarter ended June 30th, 2025, before markets open on August 12th, 2025. Gogoro's management team will hold an earnings Webcast at 8:00 a.m. Eastern Time on Tuesday, August 12th, 2025 to discuss the Company's financial and business results and outlook. What: Date of Gogoro Q2 2025 Financial Results and Q&A WebcastWhen: Tuesday, August 12, 2025Time: 8:00 a.m. Eastern Time / 8:00 p.m. Taipei Standard TimeWebcast: Approximately 24 hours after the Q&A session, an archived version of the webcast will be available on the Company's website for approximately two weeks thereafter. ABOUT GOGOROFounded in 2011 to rethink urban energy and inspire the world to move through cities in smarter and more sustainable ways, Gogoro leverages the power of innovation to change the way urban energy is distributed and consumed. Recognized by Fortune as a "Change the World 2024" company; Fast Company as "Asia-Pacific's Most Innovative Company of 2024"; Frost & Sullivan as the "2024 Global Company of the Year for battery swapping for electric two-wheel vehicles"; and, MIT Technology Review as one of "15 Climate Tech Companies to Watch" in 2024, Gogoro's battery swapping and vehicle platforms offer a smart, proven, and sustainable long-term ecosystem for delivering a new approach to urban mobility. Gogoro has quickly become an innovation leader in vehicle design and electric propulsion, smart battery design, battery swapping, and advanced cloud services that utilize artificial intelligence to manage battery charging and availability. The challenge is massive, but the opportunity to disrupt the status quo, establish new standards, and achieve new levels of sustainable transportation growth in densely populated cities is even greater. For more information, visit and follow Gogoro on X: @wearegogoro. View original content to download multimedia: SOURCE Gogoro Sign in to access your portfolio
Yahoo
8 hours ago
- Yahoo
Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025
SHANGHAI and HONG KONG, July 27, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for cancer, today announced that an abstract featuring the latest data from a Phase I/II study of the Claudin 18.2 antibody-drug conjugate (ADC), ATG-022, has been accepted for poster presentation at the 2025 European Society for Medical Oncology Annual Congress (ESMO 2025), taking place from October 17th to October 21st at the Messe Berlin in Berlin, Germany. Details of the Poster Presentation: ATG-022 (Claudin 18.2 antibody-drug conjugate)Title: Phase I/II study of Claudin 18.2 ADC ATG-022 in patients with advanced gastric/ gastroesophageal junction cancer (CLINCH)Abstract Number: 2907Presentation Number: 2113PDate: October 19, 2025 About ATG-022 ATG-022 is an antibody-drug conjugate (ADC) designed to target CLDN18.2, a member of the Claudin family of cell adhesion molecules. Under normal conditions, Claudins are located within tight junctions between cells, forming a barrier to regulate cell permeability. However, in cancer, Claudins are aberrantly expressed on the cell surface due to changes in cell polarity. CLDN18.2 is frequently overexpressed in a range of primary malignant tumors, including gastric, esophageal, cholangiocarcinoma, and pancreatic cancers. The U.S. Food and Drug Administration (FDA) has awarded Orphan Drug Designations to ATG-022, for gastric and pancreatic cancers. Data from the ongoing CLINCH study demonstrated that ATG-022 delivers robust efficacy across all levels of CLDN18.2 expression in gastric cancer patients, including those with high, low, and ultra-low expression. This broad activity positions ATG-022 as a potential market leader, capable of addressing the largest patient population with CLDN18.2-positive tumors. Furthermore, the strong efficacy observed in patients with low CLDN18.2 expression suggests promise for treating other tumor types with similar expression profiles. About Antengene Antengene Corporation Limited ("Antengene", SEHK: is a leading commercial-stage R&D-driven global biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative first-in-class/best-in-class therapeutics for the treatment of hematologic malignancies and solid tumors, in realizing its vision of "Treating Patients Beyond Borders". Antengene has built a pipeline of 9 oncology assets at various stages going from clinical to commercial, including 6 with global rights, and 3 with rights for the APAC region. To date, Antengene has obtained 31 investigational new drug (IND) approvals in the U.S. and Asia, and submitted new drug applications (NDAs) in 11 Asia Pacific markets, with the NDA for XPOVIO® (selinexor) already approved in Mainland of China, Taiwan China, Hong Kong China, Macau China, South Korea, Singapore, Malaysia, Thailand, Indonesia and Australia. Forward-looking statements The forward-looking statements made in this article relate only to the events or information as of the date on which the statements are made in this article. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect. In this article, statements of, or references to, our intentions or those of any of our Directors or our Company are made as of the date of this article. Any of these intentions may alter in light of future development. For a further discussion of these and other factors that could cause future results to differ materially from any forward-looking statement, please see the other risks and uncertainties described in the Company's Annual Report for the year ended December 31, 2024, and the documents subsequently submitted to the Hong Kong Stock Exchange. For more information, please contact: Investor Contacts: Donald LungE-mail: Mobile: +86 18420672158 PR Contacts:Peter QianE-mail: Mobile: +86 13062747000 View original content to download multimedia: SOURCE Antengene Corporation Limited Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
11 hours ago
- Associated Press
China proposes global cooperation body on AI
SHANGHAI, July 27, 2025 /PRNewswire/ -- A news report from The Chinese government has proposed the establishment of a world AI cooperation organization as part of its efforts to bolster open, inclusive and equitable artificial intelligence development and governance globally. Premier Li Qiang announced the initiative when addressing the opening ceremony of the 2025 World AI Conference and High-Level Meeting on Global AI Governance in Shanghai. Li emphasized the need for collaborative approaches to global AI governance to ensure that intelligent technologies are developed for the good of all. More than 1,000 high-level representatives from upwards of 40 countries and international organizations attended the opening ceremony of the three-day event, themed 'Global Solidarity in the AI Era'. Li said that the risks and challenges brought by AI development, such as machine hallucinations, deep fakes and AI proliferation, have aroused widespread attention. There is an urgent need to further consolidate a societal consensus on how to achieve a balance between development and security in the AI sector, he said. Li said greater emphasis should be placed on collective governance to ensure that AI ultimately benefits humanity. Given that global AI governance appears fragmented, it is essential to enhance coordination and alignment among countries around the world to establish a framework and rules for global AI governance with a broad consensus, he added. Noting that China places great importance on global AI governance and actively participates in promoting multilateral and bilateral cooperation in this regard, the premier said the nation is willing to offer more Chinese solutions to the international community and contribute more Chinese wisdom to global AI governance. In 2023, China proposed the Global AI Governance Initiative to promote an open, inclusive and fair approach to the development and governance of AI technologies. Last year, China proposed the AI Capacity-Building Action Plan for Good and for All to bridge the AI and digital divides, and to ensure the Global South benefits equitably from AI development. China actively promotes open source development, and is willing to collaborate with countries around the world to promote progress in software and hardware technologies, intensify open source initiatives, and collectively propel AI development to higher levels, Li said. Also on July 26, the conference adopted the Global AI Governance Action Plan, which calls on all parties to work in solidarity to advance AI development and governance. For more information: View original content to download multimedia: SOURCE
